Innovation is not an abstract concept, it means being able to manage, cure and prevent diseases. The results are real lives of real people transformed. And #WeWontRest until patients everywhere can see the results, in black and white: bit.ly/3OypmlM

Σήμερα στην Ελλάδα, μόνο 1 στα 5 καινοτόμα φάρμακα φτάνει εγκαίρως στους ασθενείς, με καθυστερήσεις που ξεπερνούν τον ευρωπαϊκό μέσο όρο. Αυτό σημαίνει ότι πολλοί ασθενείς περιμένουν περισσότερο ή δεν έχουν καθόλου πρόσβαση σε θεραπείες που θα μπορούσαν να βελτιώσουν ή και να σώσουν τη ζωή τους. Άμεση εξασφάλιση των καινοτόμων θεραπειών σημαίνει: ◆ Ταχύτερη πρόσβαση σε νέες θεραπείες υψηλής αξίας ◆ Πιο βιώσιμο και αποτελεσματικό σύστημα υγείας ◆ Περισσότερη έρευνα, επενδύσεις και πρόοδο Παραμονή των ασθενών χωρίς νέες θεραπείες σημαίνει: × Συνεχείς καθυστερήσεις στην πρόσβαση στα νέα φάρμακα × Η χώρα μένει πίσω στην ιατρική καινοτομία × Χάνονται ευκαιρίες για ασθενείς, υγεία και οικονομία Ποια θα είναι η επιλογή; Μάθετε περισσότερα: sfee.gr/to-ergo-mas/kampanie… #SFEE #EuropesChoice #GreecesChoice #WeWontRest @EFPIA

#Colorectal #cancer is one of the most preventable #cancers. It typically develops from polyps that can be detected & removed before they become cancerous. Don't ignore changes in your bowel habits and talk to your doctor about when to begin #ColorectalCancer screenings.

Thank you Commissioner @MarosSefcovic for this important meeting with our the @efpia Board and for your clear commitment. Together we can ensure the #EU’s #healthsecurity in any circumstance

Thank you Commissioner @OliverVarhelyi for your continued commitment and engagement with our industry & @efpia for a #stronger and more #resilient #Europe #wewontrest

An important exchange with @EFPIA representatives. The EU's pharmaceutical industry is a strategic part of our economy, driving innovation. Together, we aim to fortify Europe's medicines supply chains - the @EU_Commission is fully committed.

Europe will never give up on its health industry. Firm commitment to keep our innovation and manufacturing in Europe. Continued engagement with the industry incl. @EFPIA Board today.

📢 With @medicinesforEU & @EFPIA, we have published recommendations on electronic product information (#ePI), addressing key topics such as: 🔹 Moving towards ePI 🔹 Content 🔹 Key considerations for #EUPharmaLegislation 🔹 and much more! ➡️ Read : aesgp.eu/articles/digital-le…

@CarolineVen : the innovative biopharma sector should be treated as a strategic partner in #Belgium and in #Europe Watch interview in De Markt on @vrtnws : lnkd.in/eWGH9QCU #innovation #innovatie #België #Belgique @EFPIA

The afternoon at #POLITICOHealthCare Summit kicks off with opening remarks by @EFPIA’s Nathalie Moll, and a spotlight interview with Jakub Dvořáček. 🗣️ Don’t miss out! 🔴 x.com/i/broadcasts/1gqGvNpjb…

@NathalieMoll , DG of @EFPIA :
"The world is already polarized enough. Competitiveness and access shouldn’t be an either/or—they must be an AND." Striking the right balance is key for a stronger, more equitable health system. 🌍💊 #POLITICOHealthCare

🚀 Join us for the ERDERA launch event! 🗓️ 28 Oct 2024 ⏰ 14:00-16:15 CET 💻 Online Don't miss insights from top experts & learn how @ERDERA_org is set to change the landscape of rare diseases research! 👉 RSVP here:loom.ly/roZC5QM #RareDiseases @EU_HaDEA

Wiceminister @ignacyn uczestniczył w posiedzeniu grupy roboczej @EFPIA CEE Task Force. Grupa, w skład której wchodzą przedstawiciele firm farmaceutycznych z regionu Europy Środkowej i Wschodniej, prowadzi regularny dialog na temat rozwoju branży farmaceutycznej oraz wyzwań regulacyjnych. Uczestnicy spotkania rozmawiali m. in. o zaangażowaniu innowacyjnych technologii w rozwój branży farmaceutycznej.

1/2 ”Mitä jos Eurooppa olisikin se maanosa, joka ehkäisee seuraavan pandemian, kehittää Alzheimerin tautia hidastavat hoidot tai muuttaa kroonisia tauteja sairastavien potilaiden elämän?” ⁦@NathalieMoll⁩ ⁦@EFPIA⁩ 🇪🇺 ⁦@KauppalehtiFi⁩ kauppalehti.fi/uutiset/kilpa…

@NathalieMoll - patient engagement is crucial for medicines development for pharma companies to understand where there are unmet needs and what’s important for different patient groups @EFPIA #Vote4Patients

.@NathalieMoll, Director General at @EFPIA, adds: "There is a need for connectivity and coherence between the different legislations to make sure we make the most of the data and the information that we gather." #Vote4Patients

The key takeaways from the Rethinking #Alzheimer's Disease Perspective Paper: 🔎 Recognise the benefits of improved patient outcomes 🏥 Improve access to innovative treatments & holistic care ✔️ Build trust to allow for the implementation of guidelines 🔗braincouncil.eu/ebc-launches…

💡 Looking for partners for a potential call 9 project? To pitch at our F2F 𝗯𝗿𝗼𝗸𝗲𝗿𝗮𝗴𝗲 𝗲𝘃𝗲𝗻𝘁 𝗼𝗻 𝟭𝟮-𝟭𝟯 𝗡𝗼𝘃, 𝗽𝘂𝗯𝗹𝗶𝘀𝗵 𝘆𝗼𝘂𝗿 𝗽𝗿𝗼𝗽𝗼𝘀𝗮𝗹 on our online platform by 𝟮𝟴 𝗢𝗰𝘁.⏰ ihicalldays2024.converve.io/ #IHITransformingHealth #ResearchFunding

Roberta Savli, executive director of Public Affairs, European Federation of Pharmaceutical Industries and Associations (@EFPIA), interviene en #ObservatoriodelaSanidad 🔴En directo: youtube.com/watch?v=qeDEFBZ2…

📰 Our September newsletter is out now europa.eu/!6HxqxF 📢 News on our next call for proposals ✅ Project successes on #3Rs #HeartDisease #AntimicrobialResistance 👋 We meet new project @IHI_SYNTHIA And more! #IHITransformingHealth #HorizonEU

Pedro Facon @PedroFacon Belgian INAMI - the value assessments when introducing new medicines are more thorough than when we introduce other types of healthcare interventions and service models #EHFG @GasteinForum @EFPIA